-
In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.
J Antimicrob Chemother. 1984 Mar;13(3):237-44
PMID: 6586712
-
The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers.
J Antimicrob Chemother. 1984 Sep;14 Suppl C:63-9
PMID: 6389476
-
Reduced enteral absorption of ciprofloxacin in the presence of antacids.
Eur J Clin Microbiol. 1985 Jun;4(3):345
PMID: 3160584
-
Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae.
Infection. 1983 Nov-Dec;11(6):326-8
PMID: 6421743
-
Open, prospective study of the clinical efficacy of ciprofloxacin.
Antimicrob Agents Chemother. 1985 Jul;28(1):128-32
PMID: 2931046
-
Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results.
J Antimicrob Chemother. 1984 May;13 Suppl B:55-7
PMID: 6234276
-
Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
J Antimicrob Chemother. 1984 May;13 Suppl B:79-83
PMID: 6234279
-
The pharmacokinetics and tissue penetration of norfloxacin.
J Antimicrob Chemother. 1984 Jan;13(1):87-92
PMID: 6230344
-
Activities of newer quinolones against Legionella group organisms.
Lancet. 1983 Jul 30;2(8344):279-80
PMID: 6135099
-
In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
Antimicrob Agents Chemother. 1984 Oct;26(4):608-9
PMID: 6240224
-
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
J Antimicrob Chemother. 1984 Apr;13(4):325-31
PMID: 6233249
-
Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
J Infect Dis. 1985 Feb;151(2):291-4
PMID: 3155780
-
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.
Antimicrob Agents Chemother. 1985 Mar;27(3):350-2
PMID: 3158273
-
Enoxacin raises plasma theophylline concentrations.
Lancet. 1984 Jul 14;2(8394):108-9
PMID: 6145999
-
Ciprofloxacin distribution in prostatic tissue and fluid following oral administration.
Chemotherapy. 1985;31(1):13-8
PMID: 3156024
-
Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.
J Antimicrob Chemother. 1984 May;13 Suppl B:113-20
PMID: 6234271
-
In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).
Antimicrob Agents Chemother. 1985 Jan;27(1):4-10
PMID: 3885845
-
Resistance to ciprofloxacin.
Lancet. 1985 Jul 6;2(8445):39
PMID: 2861478
-
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
Antimicrob Agents Chemother. 1983 Aug;24(2):302-4
PMID: 6227281
-
Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.
Eur J Clin Microbiol. 1984 Aug;3(4):355-9
PMID: 6489326
-
Intraprostatic concentrations of ciprofloxacin after intravenous administration.
Lancet. 1984 Sep 22;2(8404):695-6
PMID: 6147717
-
Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
Antimicrob Agents Chemother. 1985 Sep;28(3):428-32
PMID: 2934021
-
[Ciprofloxacine: evaluation of its biliary elimination in man].
Schweiz Med Wochenschr. 1985 Mar 30;115(13):448-53
PMID: 3158073
-
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
Drugs Exp Clin Res. 1985;11(5):343-50
PMID: 2941263
-
In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.
Antimicrob Agents Chemother. 1985 Oct;28(4):514-20
PMID: 3935046
-
Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections.
J Antimicrob Chemother. 1985 Aug;16(2):211-7
PMID: 2933381
-
In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid.
J Antimicrob Chemother. 1984 Sep;14 Suppl C:33-8
PMID: 6238931
-
Norfloxacin in acute urinary tract infections.
Practitioner. 1984 Jan;228(1387):111-7
PMID: 6229726
-
Control of burn wound infections by pefloxacin and its silver derivative.
Burns Incl Therm Inj. 1984 Feb;10(3):170-8
PMID: 6586256
-
Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
Proc Natl Acad Sci U S A. 1976 Dec;73(12):4474-8
PMID: 794878
-
Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
Drugs. 1984 Jun;27(6):548-78
PMID: 6376062
-
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.
Antimicrob Agents Chemother. 1984 Mar;25(3):331-5
PMID: 6721464
-
In vitro activity of ciprofloxacin (Bay o 9867).
Antimicrob Agents Chemother. 1983 Oct;24(4):568-74
PMID: 6228192
-
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
Antimicrob Agents Chemother. 1984 May;25(5):633-7
PMID: 6233935
-
Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.
J Infect Dis. 1985 Jul;152(1):104-7
PMID: 3159811
-
Dose- and sex-independent disposition of ciprofloxacin.
Eur J Clin Microbiol. 1984 Aug;3(4):363-6
PMID: 6489328
-
Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
Eur J Clin Microbiol. 1983 Dec;2(6):548-53
PMID: 6230226
-
In vitro activity of ciprofloxacin against mycobacteria.
Eur J Clin Microbiol. 1985 Jun;4(3):345-7
PMID: 3160585
-
Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.
J Antimicrob Chemother. 1984 Nov;14(5):485-9
PMID: 6511707
-
In vitro activity of ciprofloxacin, azthreonam and ceftazidime against Serratia marcescens and Pseudomonas aeruginosa.
Eur J Clin Microbiol. 1984 Aug;3(4):368-9
PMID: 6436021
-
Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.
Proc Natl Acad Sci U S A. 1985 Jan;82(2):307-11
PMID: 2982149
-
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.
Antimicrob Agents Chemother. 1984 Apr;25(4):504-6
PMID: 6732220
-
Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophyticus and Escherichia coli.
Antimicrob Agents Chemother. 1985 Apr;27(4):449-51
PMID: 3890724
-
Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.
Antimicrob Agents Chemother. 1984 Nov;26(5):781-4
PMID: 6440481
-
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Antimicrob Agents Chemother. 1984 Dec;26(6):797-801
PMID: 6098219
-
Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans.
J Pharm Sci. 1984 Oct;73(10):1379-82
PMID: 6594505
-
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
Eur J Clin Microbiol. 1984 Aug;3(4):333-8
PMID: 6237901
-
In vitro activity of ciprofloxacin against Bacteroides, Haemophilus influenzae and Branhamella catarrhalis.
Eur J Clin Microbiol. 1984 Aug;3(4):370-1
PMID: 6333337
-
Comparative activity of ciprofloxacin against anaerobic bacteria.
Antimicrob Agents Chemother. 1985 Mar;27(3):427-8
PMID: 3158278
-
Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
Drugs Exp Clin Res. 1985;11(5):335-8
PMID: 2941261
-
DNA gyrase: an enzyme that introduces superhelical turns into DNA.
Proc Natl Acad Sci U S A. 1976 Nov;73(11):3872-6
PMID: 186775
-
Pharmacokinetics of norfloxacin in renal failure.
J Antimicrob Chemother. 1984 Oct;14(4):439
PMID: 6238930
-
Quinolones and raised plasma concentrations of theophylline.
Lancet. 1984 Sep 1;2(8401):530
PMID: 6147598
-
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
Antimicrob Agents Chemother. 1984 Mar;25(3):319-26
PMID: 6232895
-
Activity of the newer quinolones against Chlamydia trachomatis.
Br J Vener Dis. 1984 Oct;60(5):350
PMID: 6487989
-
Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis.
Antimicrob Agents Chemother. 1984 Sep;26(3):289-91
PMID: 6594970
-
Enoxacin: worldwide in-vitro activity against 22451 clinical isolates.
J Antimicrob Chemother. 1984 Sep;14 Suppl C:47-55
PMID: 6594322
-
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Eur J Clin Microbiol. 1984 Aug;3(4):328-32
PMID: 6237900
-
Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
Antimicrob Agents Chemother. 1984 Jul;26(1):13-6
PMID: 6383207
-
The pharmacokinetics and tissue penetration of ofloxacin.
J Antimicrob Chemother. 1984 Dec;14(6):647-52
PMID: 6596301
-
Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
Antimicrob Agents Chemother. 1984 Mar;25(3):342-3
PMID: 6721466
-
[Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].
Pathol Biol (Paris). 1982 Jun;30(6):394-7
PMID: 6810283
-
Activity of ciprofloxacin against genital tract pathogens.
Br J Vener Dis. 1984 Oct;60(5):316-8
PMID: 6435814
-
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.
Antimicrob Agents Chemother. 1983 May;23(5):658-63
PMID: 6223577
-
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.
Antimicrob Agents Chemother. 1984 Nov;26(5):757-61
PMID: 6517559
-
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
Antimicrob Agents Chemother. 1984 Mar;25(3):377-9
PMID: 6326666
-
Mutational resistance to 4-quinolone antibacterial agents.
Eur J Clin Microbiol. 1984 Aug;3(4):347-50
PMID: 6237904
-
In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
J Antimicrob Chemother. 1985 Jan;15(1):39-44
PMID: 3156112
-
Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
Antimicrob Agents Chemother. 1984 Oct;26(4):481-4
PMID: 6240223
-
Pharmacokinetics and tissue penetration of ciprofloxacin.
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6
PMID: 6660852
-
Nalidixic acid: an antibacterial paradox.
Antimicrob Agents Chemother. 1975 Sep;8(3):251-61
PMID: 1101818
-
[The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates].
Arzneimittelforschung. 1984;34(11):1552-4
PMID: 6596953
-
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64
PMID: 6222695
-
Pharmacokinetics of ciprofloxacin after oral and parenteral administration.
Antimicrob Agents Chemother. 1985 Mar;27(3):375-9
PMID: 3158275
-
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Antimicrob Agents Chemother. 1983 Nov;24(5):754-63
PMID: 6229216
-
In-vitro studies with ciprofloxacin, a new 4-quinolone compound.
J Antimicrob Chemother. 1984 Apr;13(4):333-46
PMID: 6233250
-
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
Eur J Clin Microbiol. 1983 Apr;2(2):111-5
PMID: 6222896
-
Comparative in vitro studies with 4-quinolone antimicrobials.
Drugs Exp Clin Res. 1985;11(5):317-29
PMID: 2941259
-
Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.
Antimicrob Agents Chemother. 1984 Apr;25(4):463-72
PMID: 6587830
-
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals.
Antimicrob Agents Chemother. 1985 Apr;27(4):657-9
PMID: 3847273
-
Pharmacokinetics of intravenously administered ciprofloxacin.
Antimicrob Agents Chemother. 1984 Aug;26(2):208-10
PMID: 6486762
-
In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
Antimicrob Agents Chemother. 1984 Jan;25(1):123-4
PMID: 6230988
-
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Chemotherapy. 1985;31(1):19-28
PMID: 3156025
-
Clinical resistance to long-term oral ciprofloxacin.
Lancet. 1985 Jun 1;1(8440):1275
PMID: 2860471
-
Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
Antimicrob Agents Chemother. 1984 Nov;26(5):741-4
PMID: 6517556
-
Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens.
J Antimicrob Chemother. 1984 Dec;14(6):641-5
PMID: 6440885
-
Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.
J Antimicrob Chemother. 1984 May;13 Suppl B:89-94
PMID: 6234281
-
The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin.
J Antimicrob Chemother. 1984 May;13 Suppl B:85-8
PMID: 6234280
-
In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives.
Antimicrob Agents Chemother. 1984 Apr;25(4):518-21
PMID: 6732221
-
The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
Eur J Clin Microbiol. 1984 Aug;3(4):344-6
PMID: 6237903
-
The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
J Antimicrob Chemother. 1984 Sep;14 Suppl C:75-81
PMID: 6238932
-
Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships.
J Med Chem. 1984 Sep;27(9):1103-8
PMID: 6381730
-
In vitro activity of enoxacin compared with norfloxacin and amikacin.
Eur J Clin Microbiol. 1985 Feb;4(1):55-8
PMID: 3157568
-
Multiple-dose ciprofloxacin kinetics in normal subjects.
Clin Pharmacol Ther. 1984 Sep;36(3):384-8
PMID: 6467798
-
Susceptibility of Legionella spp. to quinolone derivatives and related organic acids.
Eur J Clin Microbiol. 1984 Aug;3(4):373
PMID: 6489330
-
In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
Eur J Clin Microbiol. 1985 Oct;4(5):515-6
PMID: 4065142
-
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.
Antimicrob Agents Chemother. 1985 Mar;27(3):388-92
PMID: 3158276
-
In-vitro activity of enoxacin against aminoglycoside-resistant gram-negative bacilli and other clinical isolates.
J Antimicrob Chemother. 1984 Sep;14 Suppl C:1-6
PMID: 6438046